2009
DOI: 10.1002/ange.200902620
|View full text |Cite
|
Sign up to set email alerts
|

Glycosphingolipide – Natur, Funktion und pharmakologische Modulierung

Abstract: Die Entdeckung der Glycosphingolipide wird im Allgemeinen Johan L. W. Thudichum zugeschrieben, der 1884 über die chemische Zusammensetzung des Gehirns publizierte. In seinen Studien isolierte er aus ethanolischen Hirnextrakten mehrere Verbindungen, die er als Cerebroside bezeichnete. Eine dieser Verbindungen, Phrenosin (heute als Galactosylceramid bekannt), unterwarf er einer sauren Hydrolyse, aus der drei Komponenten hervorgingen. Eine Komponente identifizierte er als Fettsäure, eine andere als Isomer zur D‐G… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
11
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(11 citation statements)
references
References 252 publications
(323 reference statements)
0
11
0
Order By: Relevance
“…The myriad roles of GHs in nature include the degradation of biomass (e.g., cellulose and hemicellulose), some antipathogenic (e.g., lysozyme) or pathogenic (e.g., viral neuraminidases, NAs) functions, and a plethora of normal cellular functions (e.g., glycoprotein biosynthesis, glycoconjugate metabolism, glycogen degradation). Consequently, some of the members of this vast family of enzymes are considered extremely attractive targets for the development of therapeutic agents for the treatment of pathologies such as diabetes, cancer, influenza, AIDS and other viral infections, Alzheimer disease or lysosomal storage disorders . The efforts towards this end have led to the discovery of potent inhibitors and effectors of glycosidases .…”
Section: Introductionmentioning
confidence: 99%
“…The myriad roles of GHs in nature include the degradation of biomass (e.g., cellulose and hemicellulose), some antipathogenic (e.g., lysozyme) or pathogenic (e.g., viral neuraminidases, NAs) functions, and a plethora of normal cellular functions (e.g., glycoprotein biosynthesis, glycoconjugate metabolism, glycogen degradation). Consequently, some of the members of this vast family of enzymes are considered extremely attractive targets for the development of therapeutic agents for the treatment of pathologies such as diabetes, cancer, influenza, AIDS and other viral infections, Alzheimer disease or lysosomal storage disorders . The efforts towards this end have led to the discovery of potent inhibitors and effectors of glycosidases .…”
Section: Introductionmentioning
confidence: 99%
“…[16] In recent years, small molecules that interact with bglucosidases, either as inhibitors or as molecular chaperones, have received growing interest in medicinal chemistry. [17,18] An important issue is the target specificity of such compounds, particularly given the limited knowledge of the physiological role of GBA2/3. Until recently, few tools were available to monitor active retaining b-exoglucosidases in living cells, and the effect of potential inhibitors on these cells.…”
mentioning
confidence: 99%
“…Glycosphingolipids (GSLs) are a major component of eukaryotic cell membranes and are considered to be essential mediators in the formation of raft domains with the aid of cholesterol [1,2] . Because of their amphipathic nature, GSLs are involved in many physiological events (e. g., cellular development and differentiation, signal transduction) and pathogenesis of diseases such as cancer and pathogenic infections [3–6] . GSLs can function as cellular receptors for neighboring cells and serve as specific attachment sites for pathogenic microorganisms and secreted proteins [7] .…”
Section: Introductionmentioning
confidence: 99%